Differences in Protocol Design for Small Molecule vs. Biologic Drugs
Stability protocols for pharmaceutical products are not one-size-fits-all. Regulatory expectations, degradation pathways, storage requirements, and testing methods vary significantly between small molecule drugs and biologics. Designing a protocol that accounts for these nuances is essential to ensure product integrity, patient safety, and regulatory compliance. In this tutorial, we compare and contrast protocol design strategies for…
Read More “Differences in Protocol Design for Small Molecule vs. Biologic Drugs” »